发明名称 Local vascular delivery of adenosine a2a receptor agonists to reduce myocardial injury
摘要 <p>A stent or other implantable medical device for the local delivery of a selective adenosine receptor agonist may be utilized to reduce myocardial injury following an acute myocardial infarction. As soon as possible following an acute myocardial infarction a stent or other suitable device comprising and capable of delivering a selective adenosine receptor agonist is positioned in the blood vessel with the occlusion responsible for causing the infarct. Once in position , the stent or other intraluminal device is deployed to remove the occlusion and reestablish blood flow to the specific area, region or tissue volume of the heart. Over a given period of time the selective adenosine receptor agonist elutes from the stent or other device into the downstream coronary blood flow into the hypoxic cardiac tissue for a time sufficient to reduce the level of myocardial injury.</p>
申请公布号 IL225642(D0) 申请公布日期 2013.06.27
申请号 IL20130225642 申请日期 2013.04.09
申请人 CORDIS CORPORATION 发明人
分类号 A61L 主分类号 A61L
代理机构 代理人
主权项
地址